See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Presentation TCT 2013

Aspirin Dead, Warfarin Still Alive

Presenter: Kristen Patton

October 29, 2013

Presentation

Echocardiographic Assessment of Mitral Pathology

Presenter: Elyse Foster

October 29, 2013

Presentation TCT 2013

Transcatheter Mitral Annuloplasty Approaches for Functional MR

Presenter: Joachim Schofer

October 29, 2013

Presentation TCT 2013

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Dual Radial PCI of CTO

Presenter: St?phane Rinfret

October 28, 2013

Presentation TCT 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TCT 2013

The Next Wave: A Novel Mesh-Covered Stent and the SCAFFOLD Trial

Presenter: Peter Schneider

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(2)

Presenter: Hendrik Treede

October 28, 2013

Advertisement

Slides

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Aspirin Dead, Warfarin Still Alive

Echocardiographic Assessment of Mitral Pathology

Transcatheter Mitral Annuloplasty Approaches for Functional MR

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Dual Radial PCI of CTO

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

The Next Wave: A Novel Mesh-Covered Stent and the SCAFFOLD Trial

Technology Review and Clinical Results(2)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content